Cite
T2026 Circulating Methylated Septin 9 DNA in Plasma Is a Biomarker for Colorectal Cancer.
MLA
deVos, Theo, et al. “T2026 Circulating Methylated Septin 9 DNA in Plasma Is a Biomarker for Colorectal Cancer.” Gastroenterology (00165085), vol. 136, no. 5, May 2009, p. A-623. EBSCOhost, https://doi.org/10.1016/S0016-5085(09)62872-9.
APA
deVos, T., Tetzner, R., Model, F., Weiss, G., Schuster, M., Distler, J., Grützmann, R., Pilarsky, C., Habermann, J. K., Fleshner, P., Oubre, B. M., Day, R. W., Sledziewski, A., & Lofton-Day, C. (2009). T2026 Circulating Methylated Septin 9 DNA in Plasma Is a Biomarker for Colorectal Cancer. Gastroenterology (00165085), 136(5), A-623. https://doi.org/10.1016/S0016-5085(09)62872-9
Chicago
deVos, Theo, Reimo Tetzner, Fabian Model, Gunter Weiss, Matthias Schuster, Juergen Distler, Robert Grützmann, et al. 2009. “T2026 Circulating Methylated Septin 9 DNA in Plasma Is a Biomarker for Colorectal Cancer.” Gastroenterology (00165085) 136 (5): A-623. doi:10.1016/S0016-5085(09)62872-9.